How much worse can it get for consumers and their healthcare ? Now a report says that statins increase the risk of developing diabetes in postmenopausal women, according to a new study published in Archives of Internal Medicine. The study provides more evidence and details about the previously reported link between statins and the development of diabetes. More confusion for patients to work through.
My mother in law, when she heard the news about the link between statins and diabetes said “it’s getting to the point where I can’t trust that any of the medications I take are safe”. I wonder exactly how many people are feeling the same way.
Even newly approved medications are proving that they “are not as advertised”. Boehringer Ingelheim’s Pradaxa blood clot preventer has been associated with a slightly higher risk of heart attack or acute coronary syndrome, according to results of a meta-analysis of several studies reported in a major medical journal. So it seems that “progress” involves more risk than we originally though.
What does all this mean ?
For patients it means that they have to balance the risks vs. the benefits more than ever for EVERY prescription medication. However in a world of information overload drug marketers need to do a hell of a lot more to help clear the confusion around this new data.
Patients and consumers want good credible information which means you need to spend more time talking with people than AT them. For example a chat via social media on the new study around statins and what it really means from a leading cardiologist might help patients get to the real meaning in this study.
Content is king and if brands want to establish themselves as category leaders they need to become experts within the category with great content that people want to share not with DTC marketing talk that is being ignored.